(Ph)ighting Phages: How Bacteria Resist Their Parasites

Cell Host and Microbe

Volumn 25, Issue 2, 2019, Pages 184-194

  Rostøl, Jakob T ^a   Marraffini, Luciano ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE PROTEIN; BACTERIOPHAGE DNA; NUCLEIC ACID; RESTRICTION ENDONUCLEASE;

BACTERIAL IMMUNITY; BACTERIOPHAGE; CRISPR CAS SYSTEM; HOST PATHOGEN INTERACTION; HOST RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXIN-ANTITOXIN SYSTEM; BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HOST PARASITE INTERACTION; MOLECULAR EVOLUTION; VIROLOGY;

BACTERIA; BACTERIOPHAGES; CRISPR-CAS SYSTEMS; EVOLUTION, MOLECULAR; HOST-PARASITE INTERACTIONS;

EID: 85060853186     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2019.01.009     Document Type: Review

References (103)

1. Abudayyeh, O.O., Gootenberg, J.S., Konermann, S., Joung, J., Slaymaker, I.M., Cox, D.B., Shmakov, S., Makarova, K.S., Semenova, E., Minakhin, L., et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353, 2016, aaf5573.
2. Alawneh, A.M., Qi, D., Yonesaki, T., Otsuka, Y., An ADP-ribosyltransferase Alt of bacteriophage T4 negatively regulates the Escherichia coli MazF toxin of a toxin-antitoxin module. Mol. Microbiol. 99 (2016), 188–198.
3. Bair, C.L., Black, L.W., A type IV modification dependent restriction nuclease that targets glucosylated hydroxymethyl cytosine modified DNAs. J. Mol. Biol. 366 (2007), 768–778.
4. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
5. Bingham, R., Ekunwe, S.I., Falk, S., Snyder, L., Kleanthous, C., The major head protein of bacteriophage T4 binds specifically to elongation factor Tu. J. Biol. Chem. 275 (2000), 23219–23226.
6. Blower, T.R., Pei, X.Y., Short, F.L., Fineran, P.C., Humphreys, D.P., Luisi, B.F., Salmond, G.P., A processed noncoding RNA regulates an altruistic bacterial antiviral system. Nat. Struct. Mol. Biol. 18 (2011), 185–190.
7. Bondy-Denomy, J., Qian, J., Westra, E.R., Buckling, A., Guttman, D.S., Davidson, A.R., Maxwell, K.L., Prophages mediate defense against phage infection through diverse mechanisms. ISME J. 10 (2016), 2854–2866.
8. Brouns, S.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J., Snijders, A.P., Dickman, M.J., Makarova, K.S., Koonin, E.V., van der Oost, J., Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 (2008), 960–964.
9. Chinenova, T.A., Mkrtumian, N.M., Lomovskaia, N.D., [Genetic characteristics of a new phage resistance trait in Streptomyces coelicolor A3(2)]. Genetika 18 (1982), 1945–1952.
10. Chung, I.Y., Jang, H.J., Bae, H.W., Cho, Y.H., A phage protein that inhibits the bacterial ATPase required for type IV pilus assembly. Proc. Natl. Acad. Sci. USA 111 (2014), 11503–11508.
11. Clément, J.M., Lepouce, E., Marchal, C., Hofnung, M., Genetic study of a membrane protein: DNA sequence alterations due to 17 lamB point mutations affecting adsorption of phage lambda. EMBO J. 2 (1983), 77–80.
12. Culviner, P.H., Laub, M.T., Global Analysis of the E. coli Toxin MazF Reveals Widespread Cleavage of mRNA and the Inhibition of rRNA Maturation and Ribosome Biogenesis. Mol. Cell 70 (2018), 868–880.e10.
13. Cumby, N., Edwards, A.M., Davidson, A.R., Maxwell, K.L., The bacteriophage HK97 gp15 moron element encodes a novel superinfection exclusion protein. J. Bacteriol. 194 (2012), 5012–5019.
14. Cumby, N., Reimer, K., Mengin-Lecreulx, D., Davidson, A.R., Maxwell, K.L., The phage tail tape measure protein, an inner membrane protein and a periplasmic chaperone play connected roles in the genome injection process of E. coli phage HK97. Mol. Microbiol. 96 (2015), 437–447.
15. Datsenko, K.A., Pougach, K., Tikhonov, A., Wanner, B.L., Severinov, K., Semenova, E., Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun., 3, 2012, 945.
16. Dedrick, R.M., Jacobs-Sera, D., Bustamante, C.A., Garlena, R.A., Mavrich, T.N., Pope, W.H., Reyes, J.C., Russell, D.A., Adair, T., Alvey, R., et al. Prophage-mediated defence against viral attack and viral counter-defence. Nat. Microbiol., 2, 2017, 16251.
17. Depardieu, F., Didier, J.P., Bernheim, A., Sherlock, A., Molina, H., Duclos, B., Bikard, D., A Eukaryotic-like Serine/Threonine Kinase Protects Staphylococci against Phages. Cell Host Microbe 20 (2016), 471–481.
18. Deveau, H., Barrangou, R., Garneau, J.E., Labonté J., Fremaux, C., Boyaval, P., Romero, D.A., Horvath, P., Moineau, S., Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190 (2008), 1390–1400.
19. Doron, S., Melamed, S., Ofir, G., Leavitt, A., Lopatina, A., Keren, M., Amitai, G., Sorek, R., Systematic discovery of antiphage defense systems in the microbial pangenome. Science, 359, 2018, eaar4120.
20. Durmaz, E., Klaenhammer, T.R., Abortive phage resistance mechanism AbiZ speeds the lysis clock to cause premature lysis of phage-infected Lactococcus lactis. J. Bacteriol. 189 (2007), 1417–1425.
21. Dy, R.L., Przybilski, R., Semeijn, K., Salmond, G.P., Fineran, P.C., A widespread bacteriophage abortive infection system functions through a Type IV toxin-antitoxin mechanism. Nucleic Acids Res. 42 (2014), 4590–4605.
22. Eriksen, R.S., Svenningsen, S.L., Sneppen, K., Mitarai, N., A growing microcolony can survive and support persistent propagation of virulent phages. Proc. Natl. Acad. Sci. USA 115 (2018), 337–342.
23. Fernandes, S., São-José C., Enzymes and Mechanisms Employed by Tailed Bacteriophages to Breach the Bacterial Cell Barriers. Viruses, 10, 2018, E396.
24. Fernández, L., Rodríguez, A., García, P., Phage or foe: an insight into the impact of viral predation on microbial communities. ISME J. 12 (2018), 1171–1179.
25. Fillol-Salom, A., Martínez-Rubio, R., Abdulrahman, R.F., Chen, J., Davies, R., Penadés, J.R., Phage-inducible chromosomal islands are ubiquitous within the bacterial universe. ISME J. 12 (2018), 2114–2128.
26. Fineran, P.C., Blower, T.R., Foulds, I.J., Humphreys, D.P., Lilley, K.S., Salmond, G.P., The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc. Natl. Acad. Sci. USA 106 (2009), 894–899.
27. Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 109 (2012), E2579–E2586.
28. Goldberg, G.W., Jiang, W., Bikard, D., Marraffini, L.A., Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514 (2014), 633–637.
29. Goldfarb, T., Sberro, H., Weinstock, E., Cohen, O., Doron, S., Charpak-Amikam, Y., Afik, S., Ofir, G., Sorek, R., BREX is a novel phage resistance system widespread in microbial genomes. EMBO J. 34 (2015), 169–183.
30. Gordeeva, J., Morozova, N., Sierro, N., Isaev, A., Sinkunas, T., Tsvetkova, K., Matlashov, M., Truncaite, L., Morgan, R.D., Ivanov, N.V., et al. BREX system of Escherichia coli distinguishes self from non-self by methylation of a specific DNA site. Nucleic Acids Res. 47 (2019), 253–265.
31. Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns, R.M., Terns, M.P., RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139 (2009), 945–956.
32. Harms, A., Brodersen, D.E., Mitarai, N., Gerdes, K., Toxins, Targets, and Triggers: An Overview of Toxin-Antitoxin Biology. Mol. Cell 70 (2018), 768–784.
33. Harvey, H., Bondy-Denomy, J., Marquis, H., Sztanko, K.M., Davidson, A.R., Burrows, L.L., Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation. Nat. Microbiol. 3 (2018), 47–52.
34. Hegge, J.W., Swarts, D.C., van der Oost, J., Prokaryotic Argonaute proteins: novel genome-editing tools?. Nat. Rev. Microbiol. 16 (2018), 5–11.
35. Heler, R., Samai, P., Modell, J.W., Weiner, C., Goldberg, G.W., Bikard, D., Marraffini, L.A., Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature 519 (2015), 199–202.
36. Heler, R., Wright, A.V., Vucelja, M., Doudna, J.A., Marraffini, L.A., Spacer Acquisition Rates Determine the Immunological Diversity of the Type II CRISPR-Cas Immune Response. Cell Host Microbe 25 (2019), 242–249 this issue.
37. Hille, F., Richter, H., Wong, S.P., Bratovič M., Ressel, S., Charpentier, E., The Biology of CRISPR-Cas: Backward and Forward. Cell 172 (2018), 1239–1259.
38. Hynes, A.P., Villion, M., Moineau, S., Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages. Nat. Commun., 5, 2014, 4399.
39. Jackson, S.A., Birkholz, N., Malone, L.M., Fineran, P.C., Imprecise Spacer Acquisition Generates CRISPR-Cas Immune Diversity through Primed Adaptation. Cell Host Microbe 25 (2019), 250–260 this issue.
40. Jiang, W., Samai, P., Marraffini, L.A., Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity. Cell 164 (2016), 710–721.
41. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
42. Johnson, A.D., Poteete, A.R., Lauer, G., Sauer, R.T., Ackers, G.K., Ptashne, M., lambda Repressor and cro–components of an efficient molecular switch. Nature 294 (1981), 217–223.
43. Kaufmann, G., Anticodon nucleases. Trends Biochem. Sci. 25 (2000), 70–74.
44. Kazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, Č., Siksnys, V., Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition. Mol. Cell 62 (2016), 295–306.
45. Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G., Siksnys, V., A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems. Science 357 (2017), 605–609.
46. Kieper, S.N., Almendros, C., Behler, J., McKenzie, R.E., Nobrega, F.L., Haagsma, A.C., Vink, J.N.A., Hess, W.R., Brouns, S.J.J., Cas4 Facilitates PAM-Compatible Spacer Selection during CRISPR Adaptation. Cell Rep. 22 (2018), 3377–3384.
47. Ko, C.C., Hatfull, G.F., Mycobacteriophage Fruitloop gp52 inactivates Wag31 (DivIVA) to prevent heterotypic superinfection. Mol. Microbiol. 108 (2018), 443–460.
48. Koonin, E.V., Makarova, K.S., Zhang, F., Diversity, classification and evolution of CRISPR-Cas systems. Curr. Opin. Microbiol. 37 (2017), 67–78.
49. Lee, H., Zhou, Y., Taylor, D.W., Sashital, D.G., Cas4-Dependent Prespacer Processing Ensures High-Fidelity Programming of CRISPR Arrays. Mol Cell 70 (2018), 48–59.e45.
50. Levy, A., Goren, M.G., Yosef, I., Auster, O., Manor, M., Amitai, G., Edgar, R., Qimron, U., Sorek, R., CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature 520 (2015), 505–510.
51. Makarova, K.S., Wolf, Y.I., van der Oost, J., Koonin, E.V., Prokaryotic homologs of Argonaute proteins are predicted to function as key components of a novel system of defense against mobile genetic elements. Biol. Direct, 4, 2009, 29.
52. Makarova, K.S., Wolf, Y.I., Snir, S., Koonin, E.V., Defense islands in bacterial and archaeal genomes and prediction of novel defense systems. J. Bacteriol. 193 (2011), 6039–6056.
53. Makarova, K.S., Wolf, Y.I., Koonin, E.V., Comparative genomics of defense systems in archaea and bacteria. Nucleic Acids Res. 41 (2013), 4360–4377.
54. Makarova, K.S., Wolf, Y.I., Alkhnbashi, O.S., Costa, F., Shah, S.A., Saunders, S.J., Barrangou, R., Brouns, S.J., Charpentier, E., Haft, D.H., et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13 (2015), 722–736.
55. Manning, A.J., Kuehn, M.J., Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol., 11, 2011, 258.
56. Marraffini, L.A., Sontheimer, E.J., CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322 (2008), 1843–1845.
57. McGinn, J., Marraffini, L.A., CRISPR-Cas systems optimize their immune response by specifying the site of spacer integration. Mol. Cell 64 (2016), 616–623.
58. McGinn, J., Marraffini, L.A., Molecular mechanisms of CRISPR-Cas spacer acquisition. Nat. Rev. Microbiol. 17 (2019), 7–12.
59. McKitterick, A.C., Seed, K.D., Anti-phage islands force their target phage to directly mediate island excision and spread. Nat. Commun., 9, 2018, 2348.
60. McLaughlin, R.N. Jr., Malik, H.S., Genetic conflicts: the usual suspects and beyond. J. Exp. Biol. 220 (2017), 6–17.
61. Meeske, A.J., Marraffini, L.A., RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems. Mol. Cell 71 (2018), 791–801.e3.
62. Modell, J.W., Jiang, W., Marraffini, L.A., CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity. Nature 544 (2017), 101–104.
63. Niewoehner, O., Garcia-Doval, C., Rostøl, J.T., Berk, C., Schwede, F., Bigler, L., Hall, J., Marraffini, L.A., Jinek, M., Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers. Nature 548 (2017), 543–548.
64. Nuñez, J.K., Lee, A.S., Engelman, A., Doudna, J.A., Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity. Nature 519 (2015), 193–198.
65. Ofir, G., Melamed, S., Sberro, H., Mukamel, Z., Silverman, S., Yaakov, G., Doron, S., Sorek, R., DISARM is a widespread bacterial defence system with broad anti-phage activities. Nat. Microbiol. 3 (2018), 90–98.
66. Otsuka, Y., Yonesaki, T., Dmd of bacteriophage T4 functions as an antitoxin against Escherichia coli LsoA and RnlA toxins. Mol. Microbiol. 83 (2012), 669–681.
67. Pedersen, K., Christensen, S.K., Gerdes, K., Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45 (2002), 501–510.
68. Pedruzzi, I., Rosenbusch, J.P., Locher, K.P., Inactivation in vitro of the Escherichia coli outer membrane protein FhuA by a phage T5-encoded lipoprotein. FEMS Microbiol. Lett. 168 (1998), 119–125.
69. Penadés, J.R., Christie, G.E., The Phage-Inducible Chromosomal Islands: A Family of Highly Evolved Molecular Parasites. Annu. Rev. Virol. 2 (2015), 181–201.
70. Pyenson, N.C., Gayvert, K., Varble, A., Elemento, O., Marraffini, L.A., Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape. Cell Host Microbe 22 (2017), 343–353.e3.
71. Raleigh, E.A., Wilson, G., Escherichia coli K-12 restricts DNA containing 5-methylcytosine. Proc. Natl. Acad. Sci. USA 83 (1986), 9070–9074.
72. Redding, S., Sternberg, S.H., Marshall, M., Gibb, B., Bhat, P., Guegler, C.K., Wiedenheft, B., Doudna, J.A., Greene, E.C., Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System. Cell 163 (2015), 854–865.
73. Reyes-Robles, T., Dillard, R.S., Cairns, L.S., Silva-Valenzuela, C.A., Housman, M., Ali, A., Wright, E.R., Camilli, A., Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. J. Bacteriol., 2018 JB.00792-17.
74. Rostøl, J.T., Marraffini, L.A., Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity. Nat. Microbiol., 2019, 10.1038/s41564-018-0353-x Published online January 28, 2019.
75. Samai, P., Pyenson, N., Jiang, W., Goldberg, G.W., Hatoum-Aslan, A., Marraffini, L.A., Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity. Cell 161 (2015), 1164–1174.
76. Samson, J.E., Spinelli, S., Cambillau, C., Moineau, S., Structure and activity of AbiQ, a lactococcal endoribonuclease belonging to the type III toxin-antitoxin system. Mol. Microbiol. 87 (2013), 756–768.
77. Sapranauskas, R., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., Siksnys, V., The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 39 (2011), 9275–9282.
78. Sashital, D.G., Wiedenheft, B., Doudna, J.A., Mechanism of foreign DNA selection in a bacterial adaptive immune system. Mol. Cell 46 (2012), 606–615.
79. Scholl, D., Adhya, S., Merril, C., Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl. Environ. Microbiol. 71 (2005), 4872–4874.
80. Schwechheimer, C., Kuehn, M.J., Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat. Rev. Microbiol. 13 (2015), 605–619.
81. Seed, K.D., Lazinski, D.W., Calderwood, S.B., Camilli, A., A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494 (2013), 489–491.
82. Semenova, E., Jore, M.M., Datsenko, K.A., Semenova, A., Westra, E.R., Wanner, B., van der Oost, J., Brouns, S.J., Severinov, K., Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. USA 108 (2011), 10098–10103.
83. Shah, S.A., Alkhnbashi, O.S., Behler, J., Han, W., She, Q., Hess, W.R., Garrett, R.A., Backofen, R., Comprehensive search for accessory proteins encoded with archaeal and bacterial type III CRISPR-cas gene cassettes reveals 39 new cas gene families. RNA Biol., 2018, 10.1080/15476286.2018.1483685 Published online June 19, 2018.
84. Shiimori, M., Garrett, S.C., Graveley, B.R., Terns, M.P., Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci. Mol. Cell 70 (2018), 814–824.e6.
85. Shmakov, S.A., Makarova, K.S., Wolf, Y.I., Severinov, K.V., Koonin, E.V., Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis. Proc. Natl. Acad. Sci. USA 115 (2018), E5307–E5316.
86. Silas, S., Mohr, G., Sidote, D.J., Markham, L.M., Sanchez-Amat, A., Bhaya, D., Lambowitz, A.M., Fire, A.Z., Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein. Science, 351, 2016, aad4234.
87. Silas, S., Lucas-Elio, P., Jackson, S.A., Aroca-Crevillén, A., Hansen, L.L., Fineran, P.C., Fire, A.Z., Sánchez-Amat, A., Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems. Elife, 6, 2017, e27601.
88. Simmons, M., Drescher, K., Nadell, C.D., Bucci, V., Phage mobility is a core determinant of phage-bacteria coexistence in biofilms. ISME J. 12 (2018), 531–543.
89. Sinkunas, T., Gasiunas, G., Waghmare, S.P., Dickman, M.J., Barrangou, R., Horvath, P., Siksnys, V., In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 32 (2013), 385–394.
90. Stern, A., Sorek, R., The phage-host arms race: shaping the evolution of microbes. BioEssays 33 (2011), 43–51.
91. Sumby, P., Smith, M.C., Genetics of the phage growth limitation (Pgl) system of Streptomyces coelicolor A3(2). Mol. Microbiol. 44 (2002), 489–500.
92. Swarts, D.C., Szczepaniak, M., Sheng, G., Chandradoss, S.D., Zhu, Y., Timmers, E.M., Zhang, Y., Zhao, H., Lou, J., Wang, Y., et al. Autonomous Generation and Loading of DNA Guides by Bacterial Argonaute. Mol. Cell 65 (2017), 985–998.e6.
93. Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, Č., Nwokeoji, A.O., Dickman, M.J., Horvath, P., Siksnys, V., Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol. Cell 56 (2014), 506–517.
94. Tock, M.R., Dryden, D.T., The biology of restriction and anti-restriction. Curr. Opin. Microbiol. 8 (2005), 466–472.
95. Tormo-Más, M.A., Mir, I., Shrestha, A., Tallent, S.M., Campoy, S., Lasa, I., Barbé J., Novick, R.P., Christie, G.E., Penadés, J.R., Moonlighting bacteriophage proteins derepress staphylococcal pathogenicity islands. Nature 465 (2010), 779–782.
96. Uribe, R.V., van der Helm, E., Misiakou, M.-A., Lee, S.-W., Kol, S., Sommer, M.O.A., Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial Phyla. Cell Host Microbe 25 (2019), 233–241 this issue.
97. van Houte, S., Buckling, A., Westra, E.R., Evolutionary Ecology of Prokaryotic Immune Mechanisms. Microbiol. Mol. Biol. Rev. 80 (2016), 745–763.
98. van Houte, S., Ekroth, A.K., Broniewski, J.M., Chabas, H., Ashby, B., Bondy-Denomy, J., Gandon, S., Boots, M., Paterson, S., Buckling, A., Westra, E.R., The diversity-generating benefits of a prokaryotic adaptive immune system. Nature 532 (2016), 385–388.
99. Vidakovic, L., Singh, P.K., Hartmann, R., Nadell, C.D., Drescher, K., Dynamic biofilm architecture confers individual and collective mechanisms of viral protection. Nat. Microbiol. 3 (2018), 26–31.
100. Wang, C., Villion, M., Semper, C., Coros, C., Moineau, S., Zimmerly, S., A reverse transcriptase-related protein mediates phage resistance and polymerizes untemplated DNA in vitro. Nucleic Acids Res. 39 (2011), 7620–7629.
101. Wright, A.V., Doudna, J.A., Protecting genome integrity during CRISPR immune adaptation. Nat. Struct. Mol. Biol. 23 (2016), 876–883.
102. Zander, A., Willkomm, S., Ofer, S., van Wolferen, M., Egert, L., Buchmeier, S., Stöckl, S., Tinnefeld, P., Schneider, S., Klingl, A., et al. Guide-independent DNA cleavage by archaeal Argonaute from Methanocaldococcus jannaschii. Nat. Microbiol., 2, 2017, 17034.
103. Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O., Slaymaker, I.M., Makarova, K.S., Essletzbichler, P., Volz, S.E., Joung, J., van der Oost, J., Regev, A., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163 (2015), 759–771.